Supply Agreements In Brief
This article was originally published in The Gray Sheet
Executive Summary
Tyco Indermil: Group purchasing organization Consorta awards 50-month dual-source contract to Tyco/U.S. Surgical for Indermil tissue adhesive. Indermil (n-butyl-2-cyanoacrylate), indicated for closure of topical incisions, including laparoscopic incisions and trauma-induced lacerations in areas of low skin tension, will be distributed to Consorta's membership of roughly 300 emergency departments and 400 surgical sites treating minor skin wounds and performing laparoscopic procedures. Tyco/U.S. Surgical exclusively distributes Indermil for manufacturer Henkel Loctite (1"The Gray Sheet" Sept. 16, 2002, p. 20)...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.